EU countries like Germany are drowning in the AstraZeneca vaccine mess. Meanwhile, Britain is taking a different path.
LONDON / BERLIN – The turmoil surrounding the AstraZeneca vaccine made headlines in Germany last week. There are problems with vaccination in other EU countries and Norway. But what does Great Britain really do?
|Land||United Kingdom of Great Britain|
|Total vaccines||28.2 million with a population of about 66.65 million|
|Vaccines with AstraZeneca||15.8 with the first dose / 2.2 with the second dose|
Corona: AstraZeneca mess in Europe – Great Britain sticks to vaccine
The UK Pharmaceuticals and Health Products Regulatory Agency released this week A statement, Which also handled the astrogenic vaccine.
Great Britain is vaccinated with Biotech and Astrogeneka vaccines. According to the report, the first dose of 10.8 million from Biotech, the first dose of 15.8 from AstraZeneca and the second dose of 2.2 were vaccinated by March 21 (all news about Corona on the NRW on RUHR24.de).
In the UK, as of March 24, there were 22 reports of so-called sinus thrombosis and eight reports of other thromboses – all related to the AstraZeneca vaccine. There are no reports of vaccination with Biotech.
Corona: Great Britain has now delivered 18 million doses of AstraZeneca
At the conclusion of the report, the pharmaceutical company concluded that the benefits of coronavirus vaccines Biotech and Astrogeneneka outweigh the complications and disadvantages. They will continue to monitor progress and encourage all citizens of Great Britain to be vaccinated.
In contrast, there are reports of 30 thrombosis out of a total of 18 million vaccine doses of AstraZeneca. The risk of blood clots is very small. The drug authority now finds no reason to act differently on AstraZeneca as before.
Corona has a higher risk of getting thrombosis after being vaccinated with Astrogeneka
However, experts and scientists view the continent with concern. Again Guardian Negative press coverage of the AstraZeneca vaccine in EU countries has raised concerns that the vaccine campaign in Great Britain will be halted.
Professor Andrew Goddard, President of the Royal College of Physicians, spoke Guardian: “As far as we can tell, there is no clear evidence that thrombosis has accumulated in those we vaccinate.”
More interesting: Frank Mockenhoft, executive director of the Tropical Medical Institute in Berlin, said the domestic medicine cabinet was also dangerous.
The consensus among experts in Great Britain is clear: the risks of Govt 19 are higher than those who get a blood clot after being vaccinated with AstraZeneca.
Title List Image: © Scott Heppel / DPA